NCT07628556已完成不适用
Antidiabetic Medications and Risk of Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 74,799
- 试验地点
- 1
研究概览
简要总结
A retrospective analysis was conducted based on data of the National Health Insurance Fund in Hungary. Overall cancer risk and site-specific cancer risks were analysed in a target trial emulation design when comparing all available antidiabetic therapies to MET and monotherapies and primary combination therapies against each other. The model used in the analysis was corrected for age, gender, co-morbidities, selected cardiovascular medications and inpatient and outpatient visits.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes mellitus
- •Antidiabetic medication initiators
排除标准
- •Antidiabetic prescription in the previous 5 years
- •Recent pancreatectomy (previous or subsequent 90 days after inclusion)
研究者
István Wittmann
Full professor
University of Pecs
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Relationship between Type 2 Diabetes mellitus and CancerCTRI/2025/10/095989Dr KAUSHIK SN390
Unknown
不适用
基于医疗大数据的糖尿病及降糖药物与癌症风险真实世界研究糖尿病ChiCTR2000036722上海市促进市级医院临床技能与临床创新三年行动计划（2020-2022 年）1,330,000
已完成
不适用
Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. SulfonylureasType 2 DiabetesNCT07332156Samsung Medical Center21,692
招募中
不适用
Use of steroids in cancer treatment causing Diabetes MellitusCTRI/2024/08/072672Govt Stanley Medical College70
尚未招募
3 期
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related DiabetesPancreatic CancerNCT07272109Fudan University210